Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
Launched by MAYO CLINIC · Jan 18, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Long Term Followup of Patients Enrolled in the BEAUTY Study is a clinical trial focused on understanding why some breast cancers respond well to standard chemotherapy treatments while others do not. This study aims to collect blood and tissue samples, along with health and treatment information from patients who participated in the original BEAUTY study. By analyzing this information, researchers hope to discover important changes in the cancer that could lead to better treatment options in the future.
To participate, you need to have been enrolled in the BEAUTY study and still be alive, or if you have passed away, your family member must be willing to provide consent for using your archived tumor samples. It is important that you did not withdraw your consent during the original study. If you join this follow-up trial, you can expect to contribute valuable information that could help improve cancer treatments for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * REGISTRATION - FOR PATIENTS STILL ALIVE:
- • Enrolled in BEAUTY \[MC1137 (NCT02022202)\] and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up
- • Able to provide written informed consent
- * REGISTRATION - FOR PATIENTS WHO HAVE DIED:
- • Enrolled in MC1137 and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up
- • Existence of a family member willing to provide consent for use of archived tumor biopsies obtained after enrollment in BEAUTY
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Jacksonville, Florida, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Judy C. Boughey, M.D.
Principal Investigator
Mayo Clinic in Rochester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials